HawsGoodwin Investment Management’s Pfizer PFE Stock Holding History

HawsGoodwin Investment Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$1.74M	Sell	29,447 -817	-3%	-$40.5K	0.51%	48
2021 Q3	$1.3M	Buy	30,264 +123	+0.4%	+$5.45K	0.4%	58
2021 Q2	$1.18M	Buy	30,141 +239	+0.8%	+$9.29K	0.36%	63
2021 Q1	$1.08M	Sell	29,902 -3,028	-9%	-$108K	0.35%	64
2020 Q4	$1.21M	Sell	32,930 -1,302	-4%	-$47.8K	0.38%	58
2020 Q3	$1.19M	Buy	34,232 +2,964	+9%	+$104K	0.42%	52
2020 Q2	$970K	Sell	31,268 -3,594	-10%	-$122K	0.38%	59
2020 Q1	$1.08M	Sell	34,862 -2,546	-7%	-$86.8K	0.54%	56
2019 Q4	$1.39M	Buy	+37,408	New	+$1.33M	0.73%	56

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

HawsGoodwin Investment Management's PFE Position: Q4 2021 in Review

HawsGoodwin Investment Management reduced its Pfizer (PFE) stake by 2.7% in Q4 2021, selling an estimated $40.5K and leaving 29,447 shares worth $1.74M. The position accounts for 0.51% of the portfolio, ranked #48.

HawsGoodwin Investment Management first reported a position in PFE in Q4 2019 and has held it in 9 quarters since. 3,262 funds tracked by Wall St. Rank hold PFE as of Q4 2021.

HawsGoodwin Investment Management held 29,447 shares of Pfizer worth $1.74M as of Q4 2021.
HawsGoodwin Investment Management sold 817 Pfizer shares in Q4 2021, an estimated $40.5K.
Pfizer made up 0.51% of HawsGoodwin Investment Management's portfolio in Q4 2021, its #48 holding.
HawsGoodwin Investment Management first reported a position in Pfizer in Q4 2019 and has held it in 9 quarters since.
3,262 funds tracked by Wall St. Rank held Pfizer as of Q4 2021.

Based on HawsGoodwin Investment Management's 13F filing for Q4 2021, filed 9 Feb 2022.